313 results on '"Calleja, Jose Luis"'
Search Results
2. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals
3. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi study
4. Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi
5. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B
6. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis
7. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
8. Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D
9. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
10. Characterizing Hepatitis Delta in Spain and the gaps in its management
11. Recommendations for the future management of thrombocytopenia in patients with liver cirrhosis: A modified RAND/UCLA appropriateness method
12. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
13. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
14. Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver
15. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
16. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
17. Research Priorities for Precision Medicine in NAFLD
18. Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease
19. Consenso AEEH «Consenso sobre métodos de detección y derivación de enfermedades hepáticas prevalentes ocultas»
20. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors
21. Recomendaciones para el diagnóstico integral de las hepatitis virales crónicas en una única extracción analítica
22. Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis
23. Comparison of non-invasive fibrosis scores to predict increased liver stiffness in the general population with unknown liver disease: Searching for the primary physician's best friend
24. A nomogram as an indirect method to identify sarcopenia in patients with liver cirrhosis
25. Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
26. Mild AST elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort
27. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B
28. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury
29. Overall clinical and economic impact of non-alcoholic fatty liver disease
30. Hepatitis C reflex testing in Spain in 2019: A story of success
31. Diagnóstico en un solo paso de la hepatitis C en 2019: una realidad en España
32. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data
33. Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B
34. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
35. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
36. Restablecimiento de la actividad en los servicios de Digestivo. Recomendaciones de la SEPD, AEEH, GETECCU y AEG
37. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
38. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
39. Eliminación de la hepatitis C. Documento de posicionamiento de la Asociación Española para el Estudio del Hígado (AEEH)
40. Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
41. Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG
42. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
43. Definition of the profiles of hepatitis C virus patients based on the identification of risky practices in Spain
44. Optimización en el abordaje multidisciplinar del paciente con hepatitis C en la era de los antivirales de acción directa
45. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules
46. Hepatitis C prevalence among the migrant population in Spain: A systematic review and meta-analysis
47. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
48. PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
49. Enteritis actínica como causa de hemorragia digestiva de origen oscuro.
50. Linfoma primario de colon.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.